Skip to Main Content
APNA Clinical Psychopharmacology Institute Website Banner 8_2_23

Clinical Psychopharmacology Institute Faculty

“The content was timely and very applicable to my practice. I also loved that this was a program designed by and for psych nurses.” – 2023 Attendee

Register by May 13 for the lowest rates of the year


Expert Faculty

KEYNOTE SPEAKER
Jonathan Meyer, MD, DLFAPA
Voluntary Clinical Professor of Psychiatry, University of California, San Diego; Distinguished Life Fellow, American Psychiatric Association
Dr. Jonathan Meyer is a graduate of Stanford University and Harvard Medical School, finished his adult psychiatry residency at LA County-USC Medical Center, and completed fellowships there in Consultation/Liaison Psychiatry and Psychopharmacology Research. Dr. Meyer has teaching duties at UC San Diego and the Balboa Naval Medical Center, and is a psychopharmacology consultant to the first episode psychosis program at Balboa NMC. Dr. Meyer has lectured and published extensively on psychopharmacology and is the sole author of the chapter on the Pharmacotherapy of Psychosis and Mania for the last 3 editions of Goodman & Gilman’s The Pharmacological Basis of Therapeutics. Along with Dr. Stephen Stahl he is co-author of the Clozapine Handbook published in 2019, The Clinical Use of Antipsychotic Plasma Levels released in 2021, and The Lithium Handbook published in 2023.


John V. Campo, MD
Leonard and Helen R. Stulman Professor and Director, Division of Child and Adolescent Psychiatry at The Johns Hopkins University School of Medicine

Sattaria (Tari) Dilks, DNP, APRN, PMHNP-BC, FAANP
Retired Professor and Graduate Nursing Department Head, McNeese State University

Brittany Evans, DNP, APRN, PMHNP-BC
APP Clinical Director, Division of Child and Adolescent Psychiatry; Psychiatric-Mental Health Nurse Practitioner, Division of Child and Adolescent Psychiatry

Angela Golden, FNP-C, FAANP, FOMA
Nurse Practitioner; NP Obesity Treatment Clinic

Mary Gutierrez, PharmD, BCPP
Professor, Pharmacy Practice, School of Pharmacy, Chapman University

Josh Hamilton, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC

Lyons T. Hardy, MSN, PMHCNS, PMHNP
Assistant Professor, Virginia Commonwealth University

Capt. Joseph M. Holshoe, PMHNP-BC
Medical Director, Substance Abuse and Rehabilitation Program, Naval Medical Center Portsmouth

Sara L. Jones, PhD, APRN
Associate Professor, College of Nursing & Health Professions, McNeese State University

Laura G. Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN
Board Certified Psychiatric and Addictions Advanced Practice Nurse, APNSolutions, LLC

Sanjay J. Mathew, MD
Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research, Professor of Psychiatry & Behavioral Sciences, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine

Rebecca Myers-Settle, RN, MS, CMSRN, PMHNP-BC, NE-BC, CTTS
Psychiatric Nurse Practitioner, Winchester Community Mental Health Center

James Phelps, MD
Research Editor, Psychopharmacology Institute; Emeritus Psychiatrist, Samaritan Mental Health; Founder, PsychEducation.org

Georgia Stevens, PhD, APRN, PMHCNS, BC
Director, P.A.L. Associates

Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN
Professor, Clinical Nursing, Director Psychiatric Nurse Practitioner Specialty, The Ohio State University, College of Nursing

Daniel Wesemann, DNP, MSW, PMHNP-BC, ARNP, FAANP
Associate Professor (Clinical), Director, PMHNP Program, University of Iowa

Kirby Williams, MSN, PMHNP-BC
CEO & Founder, The PMHNP Source; Owner, Beacon Behavioral Health & Consulting

Kyle Williams, MD, PhD
Director, Pediatric Neuropsychiatry and Immunology Program, Massachusetts General Hospital